JPRN-UMIN000024166未知2 期
Phase 2 study of clarithromycin, pomalidomide and dexamethasone(ClaPD) for patients with relapsed or refractory multiple myeloma - ClaPD for RRMM
适应症
试验速览
- 阶段
- 2 期
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Pregnancy or Lactation Patients with plasma cell leukemia, cardiac amyloidosis and POEMS syndrome Patients who have peripheral neuropathy or peripheral neuropathic pain of grade 3 or more Patients with severe hepatic dysfunction, severe cardiac dysfunction, severe pulmonary dysfunction, uncontrolled diabetes, and uncontrolled hypertension Patients with tuberculosis, herpetic keratoconjunctivitis, systemic fungal infection, and with other active infections Patients with acute myocardial infarction within 6 months, with deep venous thrombosis or with pulmonary embolism within 3 years Patients who have had a complication of active double cancer within the past 5 years HBs antigen positive,HCV antibody positive, HIV antibody positive patients Patients with a clinical picture of interstitial pneumonia or fibroid lung or an abnormal bilateral interstitial abnormality on chest CT scan regardless of the presence or absence of symptoms Other patients who are,in the opinion of the caring investigator, unfit for enrollment in the study
研究者
相似试验
招募中
不适用
Phase II study of carfilzomib, pomalidomide, and dexamethasone for multiple myeloma patients who had relapsed or progressed after carfilzomib, lenalidomide, and dexamethasone (KAPPA trial)NeoplasmsKCT0006285Samsung Medical Center33
已完成
不适用
Study assessing combined therapy with clarithromycin and amoxicillin in childhood acute otitis mediaPediatric patients with childhood acute otitis media determined to be of moderate severity in accordance with the Clinical Practice Guideline for Diagnosis and Management of Acute Otitis Media in Children (2013, hereinafter referred to as the Guideline).JPRN-UMIN000015564Wakayama Medical University otolaryngology, head and neck surgery210
尚未招募
2 期
Phase II/II study of Adriamycin and Cisplatin versus Adriamycin for TC or DC resistant endometrial cancerrecurrent endometrial cancerJPRN-UMIN000009459Tokushima University hospital40
进行中（未招募）
不适用
Treatment with pomalidomide and dexamethasone for previously treated patients with AL amyloidosis.Previously treated AL amyloidosisMedDRA version: 14.1Level: PTClassification code 10002022Term: AmyloidosisSystem Organ Class: 10021428 - Immune system disordersEUCTR2011-001787-22-ITOSPEDALE POLICLINICO S. MATTEO
已完成
2 期
Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple MyelomaMultiple MyelomaNCT00538733Weill Medical College of Cornell University26